WellGen, Inc.

Amphion Innovations invests additional $1M in nutrigenomics company

Published in Medical Patent Business Week, September 30th, 2005

Amphion Innovations plc., a developer of life sciences businesses, has invested a further $1 million in WellGen, Inc., taking Amphion's stake to approximately 19 percent on a fully diluted basis.

WellGen is the first biotechnology company using nutrigenomics to discover and develop proprietary products that treat and prevent disease. WellGen uses its patented screening technology to screen naturally occurring compounds that are generally regarded as safe, against a panel of genes associated with wellness and disease.

The additional investment will support WellGen's growth plans for its nutrigenomics product pipeline. WellGen's key research programs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week

Source: Medical Patent Business Week (2005-09-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry